Handelsbanken Fonder AB grew its position in shares of Ventas, Inc. (NYSE:VTR – Free Report) by 12.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 276,474 shares of the real estate investment trust’s stock after buying an additional 31,380 shares during the quarter. Handelsbanken Fonder AB owned approximately 0.06% of Ventas worth $24,551,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also made changes to their positions in the company. Angeles Wealth Management LLC raised its position in Ventas by 4.0% during the first quarter. Angeles Wealth Management LLC now owns 3,329 shares of the real estate investment trust’s stock valued at $274,000 after acquiring an additional 128 shares in the last quarter. Bridgewater Advisors Inc. increased its stake in shares of Ventas by 2.0% during the 4th quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock worth $525,000 after purchasing an additional 133 shares during the last quarter. IHT Wealth Management LLC raised its holdings in shares of Ventas by 3.2% during the 4th quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock valued at $343,000 after purchasing an additional 137 shares in the last quarter. Sequoia Financial Advisors LLC raised its holdings in shares of Ventas by 1.2% during the 1st quarter. Sequoia Financial Advisors LLC now owns 12,894 shares of the real estate investment trust’s stock valued at $1,054,000 after purchasing an additional 148 shares in the last quarter. Finally, Parallel Advisors LLC lifted its stake in shares of Ventas by 4.6% in the 3rd quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock valued at $278,000 after purchasing an additional 175 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.
Insiders Place Their Bets
In other news, Director Michael J. Embler bought 2,500 shares of the business’s stock in a transaction on Wednesday, June 3rd. The stock was purchased at an average price of $78.81 per share, with a total value of $197,025.00. Following the transaction, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.53% of the stock is currently owned by corporate insiders.
Ventas Price Performance
Wall Street Analyst Weigh In
VTR has been the subject of a number of recent research reports. Mizuho upped their price objective on shares of Ventas from $98.00 to $104.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. JPMorgan Chase & Co. raised their target price on Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Monday, May 11th. KeyCorp boosted their price target on Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Cantor Fitzgerald upped their price target on Ventas from $97.00 to $102.00 and gave the stock an “overweight” rating in a research note on Friday, July 31st. Finally, Citigroup increased their price objective on Ventas from $100.00 to $110.00 and gave the company a “buy” rating in a report on Tuesday, August 4th. Fifteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $97.94.
Read Our Latest Analysis on VTR
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Read More
- Five stocks we like better than Ventas
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
